Equity Capital Markets

Company · CIK 1349426

Omrix Biopharmaceuticals, Inc.

CIK1349426 (SEC EDGAR)
Industry (SIC)2836 — Biological Products, (No Diagnostic Substances)
Incorporated inDE
Business addressNY
Listedno ticker on SEC record today
First annual or quarterly report2006-05-10

Offerings

2 registrations
RegistrationLabel and statusFirst filedLast eventFilings
333-139094
Registered companyFinal prospectus
 2006-12-042006-12-154
333-131107
IPOFinal prospectus
 2006-01-182006-04-215

Filings

9
FiledFilingRegistrationAccession
2006-12-15424B4Final prospectus 333-1390940000950123-06-015237
2006-12-14EFFECTDeclared effective 333-1390949999999995-06-002713
2006-12-11S-1/AAmendment 333-1390940000950123-06-015014
2006-12-04S-1Registration filed 333-1390940000950123-06-014784
2006-04-21424B4Final prospectus 333-1311070000950123-06-004920
2006-04-07S-1/AAmendment 333-1311070000950123-06-004381
2006-03-24S-1/AAmendment 333-1311070000950123-06-003659
2006-03-08S-1/AAmendment 333-1311070000950123-06-002795
2006-01-18S-1Registration filed 333-1311070000950123-06-000462

All filings of this company · CSV